Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
> création: PhDu, albi, le 15/10/2013 > rédaction: PhDu, albi, le 15/10/2013 > mise à jour : PhDu, albi le 24/4/2021
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Survolez le titre de l’article avec votre souris pour en afficher le résumé
- Advancements in autoimmune hepatitis management: Perspectives for future guidelines
- Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation
- Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report
- Interleukins in liver disease treatment
- IFN-gamma, IL-17, IL-22(+) CD4(+) subset in patients with hepatitis C virus and correlation with clinical factor
- First two cases of literature: Caustic sclerosing cholangitis due to percutaneous treatment of hydatid liver disease causing liver transplantation
- Novel high-resolution contrast agent ultrasound techniques HiFR CEUS and SR CEUS in combination with shear wave elastography, fat assessment and viscosity of liver parenchymal changes and tumors
- Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease
- Prevalence and effect on prognosis of sarcopenia in patients with primary biliary cholangitis
- Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report
- Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitis
- Efficacy of Biologics in the Treatment of Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- The pleiotropic approach to coronavirus disease-19 pathogenesis: The impact of liver diseases associated host genetic variants
- Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B
- Atezolizumab-related sclerosing cholangitis with multiple liver abscesses in a patient with lung squamous cell carcinoma: A case report
- Autoimmune Hepatitis: An Unusual Presentation
- Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses
- Novel preclinical developments of the primary sclerosing cholangitis treatment landscape
- Updates in Diagnosis and Endoscopic Management of Cholangiocarcinoma
- "Dosis sola facit venenum"-Evidence for causality in the association between ketamine and cholestatic liver injury
- Hemochromatosis: Ferroptosis, ROS, Gut Microbiome, and Clinical Challenges with Alcohol as Confounding Variable
- Lupus Hepatitis: A Rare Manifestation Revealing Systemic Lupus Erythematosus
- The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study
- Vancomycin and Ustekinumab Combination Therapy in Acute Ulcerative Colitis
- Multiloculated Liver Abscess: A Complication of Endoscopic Ultrasound-Guided Liver Biopsy
- Percutaneous microwave ablation for early-stage intrahepatic cholangiocarcinoma: A single-institutional cohort
- Rapid Electrochemical Detection of Bacterial Sepsis in Cirrhotic Patients: A Microscaffold-Based Approach for Early Intervention
- Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation
- Ulcerative colitis complicated with hypermucinous dysplasia
- Autoimmune hepatitis-primary biliary cholangitis overlap syndrome complicated by various autoimmune diseases: A case report
- Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota
- The prevalence and disease course of autoimmune liver diseases in Greenland
- Autoimmune Hepatitis on a Living Liver Donor: An Unexpected Long-Term Complication
- Celiac disease-related conditions: Who to test?
- Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
- Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis
- Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients
- Respiratory tract viral infections associated sepsis in patients with underlying liver disease: Viral sepsis an entity to look forward!
- Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections
- Treatment of autoimmune hepatitis-First-line, second-line and third-line treatment
- A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis
- Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases
- Autoimmune Hepatitis: Mycophenolate mofetil versus azathioprine as first line therapy
- Polymyositis concomitant with hepatitis B virus infection: Treatment challenges
- Protective effects of hepatic diseases by bioactive phytochemicals in <em>Fusarium oxysporum -</em> A review
- A Case Report Demonstrating the Favorable Outcomes of Using N-acetylcysteine (NAC) in Managing Hepatic Injury Induced by Amphetamine-Related Drug Toxicity: Do We Underestimate Its Potential?
- Basics and Art of Immunosuppression in Liver Transplantation
- Primary biliary cholangitis-response criteria of first-line treatment and perspectives of second-line therapy